Femoral hernia – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:34:33 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Femoral hernia – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Necessity of Cefazolin in Preventing Infections After Inguinal or Femoral Hernia Surgery https://clinicaltrials.eu/trial/study-on-the-necessity-of-cefazolin-in-preventing-infections-after-inguinal-or-femoral-hernia-surgery/ Wed, 29 Apr 2026 14:57:18 +0000 https://clinicaltrials.eu/trial/study-on-the-necessity-of-cefazolin-in-preventing-infections-after-inguinal-or-femoral-hernia-surgery/ This clinical trial is focused on understanding the necessity of using antibiotics during surgery for patients with an inguinal or femoral hernia. An inguinal hernia occurs when tissue pushes through a weak spot in the groin area, while a femoral hernia is a similar condition but occurs lower in the groin. The study will explore whether giving antibiotics, specifically cefazolin, is essential to prevent infections at the site of surgery. Cefazolin is a type of antibiotic that is often used to prevent infections during surgical procedures.

The purpose of the study is to determine if not using antibiotics is just as effective as using them in preventing infections after hernia repair surgery. Participants in the study will either receive the antibiotic cefazolin or a placebo during their surgery. The study will monitor the development of any surgical site infections in both groups to compare the outcomes.

Throughout the study, participants will undergo their scheduled hernia repair surgery and will be observed for any signs of infection at the surgical site. The study aims to provide valuable information on whether antibiotics are necessary for all patients undergoing this type of surgery, potentially leading to changes in standard medical practices. The trial is expected to continue until the end of 2025.

]]>